NEWS
You can follow the latest news of MicroViable in this section
Microviable Therapeutics will be presenting at Microbiome Connect USA
Microviable Therapeutics will participate in Microbiome Connect USA that will take place from November 14th to 16th in Boston. Claudio Hidalgo Cantabrana, CEO at Microviable, will join a like-minded community of 300 scientists and entrepreneurs [...]
Standardizing the sampling and transport of the fecal specimens to the lab
The vast majority of microbiome studies failed to address core methodological aspects including the use of anaerobic conditions, sample volume, storage etc. with a lack of protocol normalization and standardization (1). Following the agreement [...]
Microviable attends the most important international congresses
During 2023 Microviable Therapeutics has attended several leading events in the fields of microbiota, pharma and investment. In some cases we have participated as speakers with presentations and posters. This is the case of Microbiome [...]
Microbiome in the spotlight during the 2023 Princess of Asturias awards
The experts’ committee of the Princess of Asturias awards has decided to grant this year´s award for technical and scientific research to Jeffrey Gordon, Bonnie L. Bassler and E. Peter Greenberg, experts and pioneers in [...]
Microviable Therapeutics attended the talks of Bonnie L. Bassler and Peter Greenberg
Last Tuesday, Microviable Therapeutics attended the talks of Bonnie L. Bassler and Peter Greenberg, 2023 Princess of Asturias of Scientific and Technical research awards. Both explained their work on the phenomenon of quorum sensing, the [...]
Microviable will be attending HLTH 2023. Las Vegas, October 8-11
Claudio Hidalgo Cantabrana, PhD, CEO at Microviable, and our CBO, Rafael M. Permuy, MBA, will be attending HLTH 2023 event in Las Vegas (USA) from October 8th to 11th. HLTH 2023 is the preeminent event [...]